10x Genomics IncTXG
Price$90.36Intrinsic value$36.0760% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $616.9M+1.0% YoYTTM through 30 Jun 2026
Net Income -$75.1MTTM through 30 Jun 2026
Free Cash Flow $121.4MTTM through 30 Jun 2026

Margins

Current
Gross Margin70.0%
EBITDA Margin-7.8%
Operating Margin-11.3%
Net Margin-12.2%

Returns

-1.7%ROE
-1.3%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio4.46x
Net Debt-$539.8Mnet cash position
Cash & Equivalents$502.5M

Quality Metrics

Altman Z-Score29.71
Piotroski F-Score4 / 9
FCF Margin19.7%
Rule of 4020.2
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $642.8M
Diluted EPS-$0.59TTM
'19'20'21'22'23'24'25
FY2025: $-0.35

Dividend

No dividend

Capital Allocation

Capex Intensity0.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.